Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND AND OBJECTIVES: Differentiation of Alzheimer's disease dementia (ADD) and dementia with Lewy bodies (DLB) remains a challenge. Free-water imaging has been investigated in neurodegenerative diseases and was found to be associated with neurodegeneration and neuroinflammation. This retrospective cohort study tested whether Automated Imaging Differentiation for Dementia (AIDD), combining di...
BACKGROUND: Amid growing demands and constrained health care resources, effective hospital bed capacity management is crucial. Delayed hospital discharge, where patients remain in the hospital beyond the need for acute care, strains resources, affects patient outcomes, and reduces system efficiency. Predicting such delays facilitates early interventions to avert them and alleviate burdens on patie...
BACKGROUND: Oropharyngeal dysphagia (OD) commonly occurs in patients with COVID-19 disease, posing diagnostic challenges due to isolation protocols. O...
Progressive supranuclear palsy (PSP) is a heterogeneous neurodegenerative disease characterised by the accumulation of misfolded 4-repeat tau within n...
BACKGROUND: Optimal patient selection for the most effective BTK inhibitor (BTKi) partner of venetoclax in fixed-duration (FD) BTKi-venetoclax regimen...
Alzheimer's disease (AD) patients are particularly vulnerable to pneumonia and subsequent respiratory failure due to neurodegeneration-induced dysphag...
OBJECTIVE: Precision medicine requires drug repurposing methods that adapt to individual patient profiles while working within regulatory frameworks. ...
Functional magnetic resonance imaging (fMRI) derived functional connectivity (FC) is represented as graphs and as correlation or covariance matrices t...
Single-cell omics enable the dissection of cellular heterogeneity, yet the high dimensionality, inherent noise, and sparsity present significant chall...
OBJECTIVES: Leveraging routine electronic health records (EHR) for dementia detection is a growing field, but quality and clinical utility of existing...
Disease-modifying therapies for Alzheimer's disease demand precise timing decisions, yet current predictive models require longitudinal clinical obser...
Extended reality (XR), encompassing virtual reality (VR), augmented reality (AR), and mixed reality (MR), has emerged as a transformative technology i...
INTRODUCTION: Racial differences in exposure to area-level social determinants of health (SDoH) may contribute to distinct vulnerability profiles amon...
Alzheimer's disease is a progressive neurodegenerative disorder, and the most common cause of dementia, which causes 60-70 % of cases worldwide, and i...
In Parkinson's disease, non-motor symptoms precede the characteristic motor manifestations by up to 20 years. However, predicting the disease risk rem...
BACKGROUND: Parent management training (PMT) is an evidence-based intervention for children with disruptive behavior problems. However, access to care...
INTRODUCTION/OBJECTIVE: Alzheimer's disease (AD) can cause certain nervous disorders, which in turn can lead to voice disorders and abnormal values fo...
OBJECTIVE: Mild cognitive impairment (MCI) represents a critical prodromal stage associated with Alzheimer's disease and other age-related neurocognit...